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Release from polyelectrolyte multilayer microcapsules represents one of the most 
important steps enabling practical use of the microcapsules.  A number of biological 
and non-biological applications are envisaged by proper encapsulation of molecules of 
interest and their release performance.  Since the invention of the microcapsules at the 
Max-Planck Institute of Colloids and Interfaces in 1998 the work towards microcapsule 
assistant release has undergone tremendous progress. Almost simultaneously with 
development of release approaches an extensive base of applications has been advanced. 
In this progress report the release from the capsules in a solution and those immobilized 
on the surface of polymeric films is addressed.  
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1. Introduction 
The progress in engineering layer-by-layer (LbL) assembled polyelectrolyte multilayer 
capsules[1],[2]showed an strong research activities which enabled, on one hand, investigation of 
underlying principles, which govern molecular and polymeric interactions, while on the other 
hand spurred many interesting applications, many of which are directed to drug delivery.  
The capsules are fabricated by consecutive deposition of positively and negatively charged 
polyelectrolytes[3]onto liquids, cells or colloidal particles, also referred as templates.[4] Upon 
dissolution of the template by a suitable solvent, the polymeric shell remains intact, thus 
producing a hollow capsule. Flexibility of the capsule structural design, a large number of 
polymers and also organic molecules or inorganic particles used as multilayer constituents 
stimulated developments in this field. This variety of materials suitable for incorporation into 
polymeric shells determines a broad range of functionalities and tailor-made characteristics of 
the shell.  
Early research on polyelectrolyte multilayer capsules concerned understanding the properties 
of polymers comprising the shell, employment of different sacrificial templates, investigation 
of capsule response to various stimuli and development of drug delivery carriers using the 
microcapsules.[5]Recent developments in the area of polyelectrolyte multilayer capsules were 
mainly concentrated on: a) understanding physico-chemical aspects of the capsule fabrication 
(e.g. an influence of polyelectrolyte charge,[6] an interplay between hydrophilic and 
hydrophobic interactions, synthesis of the templates) which promoted essential functionalities 
such as encapsulation and release performance,[7] and b) applying this knowledge for 
development of a broad range of applications, most notably in the bio-medical area.[8] 
In this progress report, we describe the basics of encapsulation and release, and present an 
update on the recently developed applications. We elaborate on future trends in the area and 
provide an outlook. Two main trends, which should shape future developments can be clearly 
identified in this research area. One of these directions concerns in depth elaboration of physico-
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chemical principles which would make broader the capsule functionalities. Another trend, 
which partially depends on novel functionalities, is subsequent development of new 
applications, particularly bio-medical and drug delivery applications. These applications should 
stimulate development of not only applied aspects for the capsule use, but also help to 
understand fundamental principles behind polyelectrolyte self-assembly and release 
mechanisms. We first briefly describe main principles used for capsule assistant molecule 
encapsulation and release and then highlight capsules applications including catalysis, drug 
delivery, theranostics.  
 
 
2. Diversity of polyelectrolyte multilayer capsules and encapsulation methods  
 
2.1. Capsule assembled based on electrostatic interactions  
First and foremost polyelectrolyte multilayer capsules were fabricated using electrostatic 
interactions between self-assembled polyelectrolytes.[9] Consecutive deposition of oppositely 
(positively and negatively) charges polymers is applied to assemble multilayer shell. The 
strength of the interaction as well as multilayer response to chemical stimuli can be controlled 
by the structure of the used polymers, the state of polymers upon adsorption, their isoelectric 
point, grafting and charge density.  
 
2.2. Capsule assembled using hydrogen bonding  
Hydrogen bonding has been identified as a promising interaction for LbL assembly.[10] 
Microcapsules made of polymethacrylic acid (PMA) and polyvinylpyrrolidone (PVPON) were 
made by Sukhishvili and co-authors.[11] Such microcapsules swell at acidic and basic pH and 
the pH-sensitive loading of dextran and its release was reported.[6] The capsules were also 
sensitive to changes in ionic strength. Addition of high concentration of salt can be used for 
promoting the capsule cargo release.  
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It is important to highlight that adsorption of polycations while building the shells induces the 
release. It was shown that microcapsules prepared similarly using different poly(carboxylic 
acids) exhibited different pH thresholds for shell swelling. Recently, Tsukruk and co-
workers[12] have prepared tannic acid based multilayer microcapsules through hydrogen 
bonding with acceptor polymers such as PVPON, poly(N-vinylcaprolactam), and poly(N-
isopropylacrylamide). These microcapsules were stable over a wide pH range from 2 to 10 and 
exhibit pH-sensitive permeability changes to dextran. In addition, gold nano-particles (AuNP) 
were grown in the tannic acid-containing capsule wall under mild conditions, which suggests 
the possible use of AuNP as a scaffold for the introduction of proteins or DNA in the capsule 
through electrostatic or covalent modification.  
 
2.3. Cross-linked and ion cross-linked capsules  
Another interesting method to produce polymeric capsules is the crosslinking of hydrogels[13] 
by metal ions. Both polyelectrolyte multilayer shells[14],[15] and templates[16],[17] can be cross-
linked. In the latter case a possibility of using Ca2+ ions represents an interesting step because 
it can be removed by EDTA during the dissolution similarly to dissolving CaCO3 template. 
Availability of silver nanoparticles is particularly interesting for release application, especially 
if their distribution can be controlled.[18] Further development was conducted by adsorption of 
the alginate onto the porous colloids templates followed by jellification with silver ions. After 
the calcium carbonate dissolution, the stable silver alginate capsules were formed.  
 
2.3. Diversity of capsule shapes tuned by choice of a sacrificial template  
2.3.1. Anisotropic shapes 
The properties of microcapsules depend also on templates on which they are assembled,[4] while 
two main types of templates can be distinguished - non-porous templates possessing smooth 
surface and porous templates. One classical example of such smooth non-porous templates is 
silica or polystyrene particles. Such templates are often commercially available and possess 
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good monodispersity and uniform multilayer shell thickness. Due to a complete dissolution of 
silica templates, microcapsules produced on them are very reproducible.  
In the case of porous templates such as calcium carbonate vaterite crystals, the significant 
advantages includes relatively low cost of production and the possibility to use pores for 
encapsulation of molecules into the formed capsule. Calcium carbonate particles[19] have been 
extensively used as easy produced porous sacrificial templates, which were shown to target 
cancer cells.[20] Release mechanisms based on crystal recrystallization has been elaborated.[21] 
Recent findings have revealed that the geometry of the templates could affect their uptake into 
cells by phagocytosis.[22] Attachment of particles to the specific site of cells can be tuned not 
only via surface chemistry but also by changing the geometry of the particles even at the 
nanoscale.[23],[24],[25] Thus, future trends in particle assisted drug delivery are seen towards novel 
methods of synthesis and elaboration of anisotropic particles which in some cases may even 
resemble such natural entities as bacteria.[26],[27] 
The flexibility of polyelectrolytes allows keeping different shapes of the formed multilayer 
capsules after decomposition of the sacrificial solid templates.[28] Shchepelina et al compared 
morphology, mechanical properties, and permeability of hydrogen-bonded LbL microcapsule 
shells assembled on square cadmium carbonate against the same shells assembled on spherical 
silica.[23] The patterned template-assisted assembly of the cubic micro-particles driven by the 
competing capillary, Coulombic, and van der Waals forces in comparison with the traditional 
spherical colloidal microparticles had been studied by Lisunova et al.[29] 
Doxorubicin cubes have been identified as effective carriers of doxorubicin in cells,[30]while 
cubic shape has been reported to be effective for the interaction of LbL polymeric particles with 
breast cancer cells.[31] Transformation of capsules of different shapes has been reported by the 
group of Kharlampieva.[32] Such pH shell shape dependence of was used by Kozlovskaya et 
al[27] for pH triggered intercellular response and release by the capsules degradability or 
swelling mechanisms.  
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Recent developments in the area of design of new sacrificial templates for microcapsules 
include anisotropic shapes.[33] A set of differently shaped (spherical, elliptical, and squared) 
CaCO3 particles was synthesized through changing the stirring speed, time, pH value, and salt 
ratio and the loading capacity of such capsules was studied.[34] These particles were further used 
for the build-up of polyelectrolyte multilayer capsules loaded with dextran molecules which 
replicate the initial shape of the CaCO3 templates after their decomposition with EDTA. 
Template size control[21] as well as their porosity[35] are of high interest for biological 
applications and stimulates further works towards synthesis of the calcium carbonate templates.  
 
2.3.2. Isotropic shape, anisotropic shell composition – Janus  capsules 
Janus capsules represent a special class of anisotropic carriers – their shape is uniform, but their 
shell would have two distinct parts. They have been the subject of extensive research,[36],[37],[38] 
geared by possibilities of improved targeting and uptake. In the case of Janus capsules, a widely 
used approach for their fabrication is partial embedding and partial protection of the shell for 
subsequent modification of the unprotected part of the shell.[36] Using such a protection, Kohler 
et al has demonstrated that the degree of protection or the degree of patchiness can be controlled 
by adjusting of softness of the polymeric multilayer films working as matrices for trap of 
capsules to be modified to produce Janus capsules.[39]An innovative method of assembling 
Janus capsules is based on fusion of capsules, carried out either by salt or temperature.[40] 
Microcapsules with anisotropic shell composition are best suited for targeting specific cells or 
even cellular compartments.[41] 
 
2.3.3. Anisotropic shape, Janus capsules – multicompartment anisotropic capsules  
Fabrication of Janus capsules was reported by using partial masking in thick, biocompatible, 
hydrogel-like poly-L-lysine)/hyaluronic acid or (HA/PLL) films.[42],[43] Capsules and particles 
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with two half-shell patches were demonstrated. Peculiarly, the unprotected part of capsules was 
modified with smaller capsules creating thus anisotropic, multicompartment, Janus capsules.  
 
2.4 Multicompartmentalization  
A carrier which is capable of carrying several molecules in one entity, but in different 
subcompartments, a multicompartment vehicle, is often sought in the field of drug delivery.[44] 
An analog with small lipid vesicles has also been reported.[45] Recently, 
multicompartmentalization has been shown for polymersomes.[46] The capsule analogues of 
such multicompartment carrier are capsosomes.[47],[48] They represent polyelectrolyte capsules 
containing structurally intact liposomes with a payload. Poly(styrene sulfonate) (PSS) and 
poly(allylamine hydrochloride) (PAH) were used for assembling polymeric capsules and 50 nm 
zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) liposomes were used as a 
cargo. The advantage of such type of the multicompartments is the stability against chemical 
degradation allowing repetitive function over an extended period of time. The further 
assemblies of capsosomes were performed by using biodegradable poly(N-vinyl pyrrolidone) 
(PVP) and thiol-modified poly(methacrylic acid) (PMASH).[49] They achieved high retention 
of luciferase and b-lactamase within sub-compartment liposomes during 14 days.  
Hierarchy of multicompartment capsules include concentric and pericentric as some of the most 
widely used carriers. The preparation of pericentric carriers can be achieved when situating 
multiple subcompartments concentrically around the larger inner core or compartment. Porous 
calcium carbonate particles is one of good promising examples as sacrificial template material. 
These particles were used as inner core bearing large (enzyme horseradish peroxidase (HRP)) 
molecules while small molecules (Amplex Red) have been loaded into liposomes subsequently 
attached via electrostatic interaction to the CaCO3 particles. First, the inner particle or larger 
inner core is synthesized. The enzyme-catalyzed reaction was observed during disruption of the 
outer compartments by ultrasound by confocal microscope.[50] Not only inorganic particles are 
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useful for the assembly of complex carriers, but also polymer hydrogel microcapsules with tens 
of 300 nm subcompartments with permeable shell have been demonstrated. By applying 
chemical stimuli these multicompartments have been degraded in a selective manner.[51] Recent 
developments in the area of multicompartment microcapsules include functionalization with 
polymersomes.[52]  
 
 
3. Encapsulation into and release from microcapsules  
3.1. Encapsulation into microcapsules  
Encapsulation strategies for loading of molecules of interest into polyelectrolyte multilayer 
capsules can be very diverse, but this step influences the release from microcapsules. 
Responsiveness of polyelectrolytes to various stimuli has been one of the main features, which 
enable control over properties of the capsules and different encapsulation strategies.[8] For 
example, changing the pH of the solution in which capsules are immersed can lead to 
protonation/deprotonation of weak polyelectrolytes - this affects the charge balance within the 
shell and can be used either for shrinking or swelling of the shell, thus changing its permeability 
and allowing for encapsulation of molecules.[6] Other distinct examples include incorporation 
of such polyelectrolytes, possessing hydrophobic moieties, as poly(styrene sulfonate) (PSS) or 
varying the charge compensation through the number of polyelectrolyte layers, which can be 
used for shrinking or swelling of capsules upon raising the temperature above the glass 
transition temperature of the polyelectrolyte multilayer complex[7],[53].  
A distinct example of the latter approach is synthesis of calcium carbonate templates in the 
presence of molecules to be encapsulated, the so-called co-synthesis. Encapsulation can be 
conducted into already prepared capsules or carried out simultaneously with preparation of 
templates for microcapsules.[54] Advantages of such approach include high loading capacity and 
relatively fast fabrication of capsules (since molecules to be encapsulated are already 
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incorporated into the templates during capsule fabrication). Post-loading was also conducted 
for anticancer doxorubicin,[55] including emulsion templates.[56]  
Another approach is based on already synthesized or commercially available templates. In this 
approach, the polyelectrolyte shell is first built around those templates, which are subsequently 
dissolved, and molecules to be encapsulated are incorporated afterwards, typically using 
external stimuli. The thermal and pH encapsulation methods were first developed on 
commercially available templates[4] (SiO2, polystyrene, etc).  
It can be noted that the principles discussed here polymeric microcapsules are also relevant for 
other nanocarriers.[57]  
 
3.2. Release from polyelectrolyte multilayer capsules in solution 
Release mechanisms are closely related to drug delivery applications. Indeed, just as the 
encapsulation, the release mechanisms are based on physical, chemical, or biological stimuli,[8] 
as shown in Figure 1. This functionality directly depends on molecules, particles or additives 
incorporated into polyelectrolyte multilayer shell. Approaches of initiating release from 
capsules depend on the type of external influence or stimulus.  
   
a)           b) 
Figure 1. Release from microcapsules: a) in regard with the application point of view: in a 
solution versus immobilized in films; and b) in regard with mechanisms using physical, 
chemical, and biological stimuli. Image b) is reproduced from[3] with permission of the Royal 
Society of Chemistry.  
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We look further at biological, physical and chemical stimuli[8] for release from microcapsules. 
Biological stimuli, although often used for targeting, can be also used for release through 
biodegradability[58],[59] or specific linkage dependence, wherein disulfide linkages, described by 
the group of Caruso can be degraded intracellularly.[60] In the latter work, HeLa cells were 
incubated in vitro with PMASH capsules – capsules based on poly(methacrylic acid) (PMA)-
modified with thiol groups (PMASH). Disulfide bonds were then cleaved, while thioesters 
remained stable. Using the lipophilic dye DiI (1,10-dioctadecyl-3,3,30,30-
tetramethylindocarbocyanine perchlorate) it was found that redox-sensitive PMASH capsules 
allowed intracellular release of DiI as evidenced by the distribution of DiI through intracellular 
hydrophobic domains. The extracellular medium is known to be oxidative, while the cellular 
cytoplasm is a reductive environment. However, PMLC are commonly internalized in 
phagosomal compartments that are also oxidative and should therefore not favor decomposition 
of PMASH capsules. That reason is that PMASH capsules did allow release of their payload was 
attributed to the role of thiols associated with cell surface proteins. This so-called exofacial 
thiols catalyzed redox-activated release from the capsules and blocked exofacial thiols 
completely abolished intracellular release, although the capsules were still internalized.  
Physical stimuli stand-out for their controllability and non-disruptiveness to the environment. 
Laser-nanoparticles interaction has been demonstrated as one of the first controllable release 
approaches. A laser can be easily coupled into a microscope, it can be non-invasive (by 
appropriate choice of the wavelength, i.e. near-IR for biomedical applications), and offers a 
high temporal and spatial control over light application to a sample. Polymers comprising the 
shell of microcapsules do not absorb in the visible and near-IR part of spectrum, so one needs 
to incorporate such active centers as light absorbing particles[61],[62],[63] or molecules[64],[61],[65]. 
Incorporating these active centers into the walls of the capsules can be used for controlling 
release of encapsulation materials or even release only a portion of encapsulated materials[66] 
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by modulating the permeability of the polymeric membrane. In this case, the modulation of the 
polymeric membrane took place by raising temperature on metal nanoparticles just slightly over 
the glass transition temperature of the polyelectrolyte multilayer complex. Peculiarly, a similar 
modulation on lipid membranes[67] or disruption of the membrane of other types of carriers, red 
blood cells,[68] was achieved, although the mechanism in that case is different. The role of metal 
nanoparticles here is to locally generate an increase of temperature by conversion of light 
energy into heat.[69] Such methods are extensively used for drug delivery because they do not 
alter the chemical composition of the environment, and, therefore, could be conducted under 
physiological conditions where changing pH or ionic strength is not a viable option. Advances 
in the area of release also include site-specific release, where nanoparticles are immobilized 
onto a specific place of the capsule shell or the laser is directed onto a very specific place even 
for an uniformly functionalized microcapsule.[70] For all of the above approaches, it is essential 
to control the concentration of nanoparticles upon adsorption and their distribution.[69],[18] 
Ultrasound is an another method of inducing the release. Generally, it is widely used for the 
synthesis of various nanomaterials, such as coating carbon nanotubes and noble metals and in 
various biomedical applications: destruction and fragmentation of contrast agents, gas release, 
polymer destruction, and in drug delivery.[71] But ultrasound was also used for breaking the 
capsules for releasing of encapsulated materials.[72],[73] Nanoparticles were used here to increase 
the density of microcapsule shells, and it was found that nanoparticles adsorbed on 
microcapsules affect the action of ultrasound on their shells.[72] Powers in the range of 100-500 
W at frequencies of 20 kHz were applied for capsule destruction. High-frequency ultrasound 
(1.2 MHz, 0.33 W cm-2) was applied to nanocomposite microcapsule with zinc oxide 
nanoparticles in polymeric shell and monitored in situ upon exposure of their aqueous 
suspension to ultrasound. Increasing the sensitivity of microcapsules to ultrasound represents 
one of the goals in this direction.[74]  
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Multilayered hollow capsules can also be functionalized with magnetic nanoparticles for release 
and targeted delivery. Ferromagnetic cobalt nanoparticles containing a layer of gold (Co/Au) 
were incorporated into the assembly of PSS and PAH polyelectrolyte multilayer shells. 
Subsequently, application of alternating magnetic fields resulted in increased shell permeability. 
Lu and co-workers showed that magnetic field affects the permeability of microcapsules by 
acting on aggregates of nanoparticles.[75] The permeability of the 
(PSS/PAH)4(PSS/Co@Au)1(PSS/PAH)6 capsule for FITC-dextran before applying alternating 
magnetic fields is negligible; FITC-dextran is blocked from diffusion into the capsules. After 
applying an alternating electromagnetic field (1200 Oe, 150 Hz) to the capsule/FITC-dextran 
mixture for 30 min, the capsules became permeable for the dextran. Although the magnetic 
activation of microcontainers is a good candidate for controlled drug delivery, the long exposure 
time and the strong magnetic field are required to permeabilize the capsule shell leading to an 
increase in the temperature which is problematic for application of temperature sensitive 
biomolecules such as proteins.  
Microcapsule rupture and release can also be achieved by disrupting the shell membrane by 
mechanical deformation. Mechanical properties are fundamentally important because they 
determine capsule stability and integrity. Design of mechanically stable capsules is of high 
interest since they are typically deformed upon intracellular uptake,[76],[77] leading to losses in 
the amount of delivered material. A new method consisting in release upon mechanical 
deformation of polyelectrolyte multilayer capsules has been developed by combining 
fluorescence microscopy with AFM force spectroscopy.[78] Such an approach has allowed to 
measure the details of release upon mechanical deformation and forces exerted by cells upon 
uptake.[79]  
Chemical stimuli (such as pH, salt, solvents) are more often used for encapsulation than release, 
because they are more disruptive than biological and physical stimuli. Exceptions in this area 
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include a specific design of the polyelectrolyte multilayer shell to induce the release, for 
example, “click” chemistry.[80]  
 
3.3. Release from polyelectrolyte multilayer capsules immobilized onto polymeric 
surfaces 
Polyelectrolyte multilayer capsules in a solution target a variety of applications where particles 
or capsules can be used as carriers. Here we look at microcapsules immobilized onto polymeric 
films, where a different sort of application is targeted. The films themselves can be used as 
reservoirs of drugs, which can be subsequently delivered from the films.[81],[82],[83],[84] Enzyme 
encapsulation can be also performed with films.[85] Release of plasmid DNA from intravascular 
stents has been shown as an interesting application,[86] while controllable release directly from 
the surface of films by laser light has been identified as a potential trend-setting 
development.[87],[88] Hydrolytic degradation of films can be used as another mechanism 
promoting release from the polymeric films.[89] Release from phospholipid polymer and 
poly(vinyl alcohol) hydrogels connected by reversible covalent bonding on titanium 
demonstrates the versatility of surfaces as drug delivery reservoirs,[90] while polyarginine 
/hyaluronic acid films[91] exhibit antibacterial properties.[92] 
Cell-surface interaction and delivery of biomolecules from the capsules into cells from the 
surfaces is also of high interest for extracellular delivery. In this case, microcapsules are 
immobilized or embedded on the surface of films, on which cells are subsequently grown. LbL 
films are good candidates in regard with the films, but it is the so-called exponentially grown 
films that play an important role here.  
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Figure 2. Adsorption of microcapsules onto the (PLL/HA)24/PLL films. (a-c) CLSM images 
of the capsules exposed to near-IR light irradiation. (d) CLSM image of the film surface (the 
film is prepared with PLL-FITC; black lines are scratches made by a needle for easier film 
imaging). (e) Cross-sectional profile of the capsules after step-by-step laser exposure (the 
sections from top to bottom correspond to the images a-c, respectively). The scale bar in parts 
a-c and f is 4 μm. (f) TEM images of the capsules after light irradiation. The scale bar in part 
d is 25 μm. Reproduced with permission from[93] the American Chemical Society.  
 
The exponentially built multilayer films[94] are assembled into very thick (the thickness is on 
the order of micrometres), compared to normal LbL films (typically the thickness is on the order 
of nanometers). These thick LbL films allow immobilization of the microcapsules, which, once 
immobilized onto the surface of films, can release their cargo by the laser acting on 
nanoparticles in the shells of capsules.[93] One such example is shown in Figure 2, where the 
red channel (top row, red channel) shows sequential release of one capsule and then another 
capsule, Figure 2 (a-c). The surface of the films can be clearly seen in the green channel, Figure 
2d, where two black lines are drawn for identification purposes. The red microcapsules are 
located in a slightly bleached area (white zoomed-in area). Further, we discuss various 
biomedical applications of microcapsules.[95] 
 
4. Bio-medical and drug delivery applications  
 
4.1.Intracellular delivery 
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Microcapsule delivery into living cells has seen early interest and underwent significant 
developments.[96] Microcapsules were shown to be effectively uptaken by cells. Subsequent 
studies reported intracellular delivery and controlled release inside cancer cells[97] as well as 
release through biodegradation. Fundamental processes relevant to immunology have been also 
investigated during the course of cell experiments. In such studies, microcapsules possessing 
light absorbing nanoparticles in their shells were incorporated inside living cells. Subsequent 
controlled release of encapsulated peptides led to peptide-MHC Class I protein complex 
formation and eventual surface presentation of such a complex at the cell surface.[98] That 
essentially confirmed a fundamental question of immunology – the surface presentation of 
small peptides – in an experiment, which allowed to measure the time scale of the surface 
presentation of peptides and mechanisms of its intracellular transport. Recently, release of 
anticancer agents, proteins and nucleic acids (mRNA), where plasmonic nanoparticles were 
used for remote release, was investigated.[99] Further application of this technique was 
conducted in regard with release of active enzymes.[100]  
 
4.2.Moving the cargo on the surfaces 
Efforts have been made to exploit microcapsules for the active transport of cargo, which is 
relevant for release around and functionalization of surfaces.[101] Special attention is paid to 
self-regulated and autonomous motion. For this purpose, the integration of chloroplastic 
ATPase into the microcapsule wall containing of a lipid bilayer has been demonstrated. This 
was used for the synthesis of ATP by such composite capsule. The driving force for ATP 
synthesis, catalyzed by ATPase, was provided by an acid–base transition between the interiors 
and exteriors of the capsules. Later on ATPase was also integrated into lipid-coated hemoglobin 
or glucose oxidase capsules. ATP could be synthesized in the protein microcapsules by utilizing 
proton gradients, which were produced from oxidation and hydrolysis of the glucose. This was 
catalyzed either by the added or immobilized glucose oxidase (GOD). The most recent advance 
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reported by the same group is the construction of a dynamic biomimetic system by bringing 
kinesin coated microcapsules close to microtubules. The multilayer capsules which can drive 
cargos such as vesicles, proteins, and organelles were functionalized with kinesin molecules 
and were put along microtubules. The microtubules act as tracks for the kinesins coated 
capsules and guide them to move directionally (Figure 3). Both hollow and filled capsules are 
transported by kinesin motors along microtubules. Further, the microcapsules were attached to 
microtubules through biotin–avidin interaction, which also act as a transport shuttle of the 
attached microcapsules.[102] These approaches provide a great promise to design complex self-
regulated nanodevices by using biological motors for mimicking efficient intracellular 
transport.  
 
Figure 3. a) Schematic illustration of a multilayer capsule as a cargo driven by kinesin motors 
along a microtubule. (b) Time-lapse images of a capsule, coated with kinesin molecules, 
moving along a microtubule. Adapted with permission from ref.[102] Copyright 2009, Elsevier. 
 
4.3. Biomimetic, biochemical and mechanical sensors  
Although the size of microcapsules can vary in a broad range, most of the capsules have been 
made with diameters around several micrometers. That falls in the same size range as, for 
example, red blood cells (~ about 7 µm), and one might assume that the microcapsules would 
deform similarly to red blood cells. In-vitro experiment can be designed to investigate such 
deformability, where capsules encounter similar obstacles of passing through the blood 
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capillary vessel as the RBCs do, if they similarly circulate in the blood stream. Therefore, their 
deformability and recovery after passing through a thin capillary channel is of practical 
importance and highly demanded . Another biomimetic application has been shown to construct 
capsule-in-capsule assembly, which could resemble artificial cells.[103] 
Biochemical sensing has been first shown by means of the example of monitoring intracellular 
pH. This approach was implemented through encapsulation of pH sensitive polymer inside 
capsules and incorporating such capsules inside living cells.[104] Fluorescence read-out has 
facilitated the signal recording. A next step in the area of biochemical sensing was taken in the 
direction of determining the concentration of oxygen in water.[105] 
Mechanical sensing using microcapsules was demonstrated recently by measuring mechanical 
properties of microcapsules by colloidal probe AFM and subsequent correlation of these data 
to those obtained upon uptake of microcapsules. These studies revealed that upon uptake cells 
exert forces on the order of 0.2 µN. Mechanical properties can be also controlled by cross-
comparison of microcapsules with red blood cells – some experiments were done by squeezing 
the microcapsules through a microfluidic channel.[106] 
Enhancement of mechanical properties is a very relevant aspect, because early study revealed 
that microcapsules without chemical reinforcement of their walls cannot deliver encapsulated 
cargo. Additional layers can be used for enhancement of mechanical properties[107] and for 
tuning the release,[108] while organic molecules deposited in the polyelectrolyte multilayer shell 
can be used for inducing chemical cross-linking. It was reported that metal nanoparticles 
provide additional links between polymers and thus enhance mechanical properties.[109] This 
enhancement is concentration dependent and can be tuned by choosing an appropriate density 
of nanoparticle coverage. Carbon nanotubes can be used as an alternative for enhancement of 
mechanical properties upon deposition onto polyelectrolyte multilayers.[110] 
 
4.4. Delivery relevant for gene therapy  
  
18 
 
A range of important applications stems from delivery of oligonucleotides as well as other 
biologically relevant molecules, such as DNA, siRNA. One particular area that could be singled 
out here is gene therapy, where the main goal is to introduce and replace genes. DNA itself 
could be either used as a building block of the capsule shell or as material to be delivered.  
As an alternative to the use of electrostatic interactions, the Caruso group has elaborated on the 
use of hydrogen bonding to incorporate oligonucleotides either inside or in the wall of 
polyelectrolyte capsules.[111] In another study, oligonucleotides accumulated in the pores of 
amine modified mesoporous silica microspheres due to electrostatic interactions. Subsequent 
multilayer build-up of hydrogen bonded PMA and PVPON followed by etching of the silica 
core templates and yielded hollow capsules with stably encapsulated oligonucleotides.[60] In 
addition, DNA hybridization based on hydrogen bonding between homopolymeric 
oligonucleotide blocks has been explored to construct multilayered capsules. In spite of the 
feasibility to incorporate nucleic acid based biomacromolecules into polyelectrolyte capsules 
or to use them as wall constituent, there are only few reports of functional biological 
experiments showing polyelectrolyte capsule mediated gene delivery. Selina et al reported on 
the in-vivo use of a swine fever DNA vaccine by incorporating plasmid DNA into degradable 
biopolymer based dextran sulfate/carrageenan capsules.[112] Parak and co-workers 
demonstrated release from lysosomes by proton sponge effect.[113]  
 
4.5. In-vivo drug delivery  
Real experiments with animals represent yet another venue of extensive range of application of 
multilayer capsules. Up until now, most studies concerned targeting tissue or cell without 
circulation. Microcapsules were shown to promote treatment of colorectal cancer.[114],[115] The 
biomimetic polymeric microcapsules with the immunosuppressive and tumor-recognition 
functionalities of natural leukocytes have been developed for the improving the accumulation 
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of capsules in tumor site through the molecular recognition of membrane-bounded proteins of 
CLMVs in vitro and in vivo.[116] In-vivo studies represent an essential functionality,[117] so it is 
envisioned that more research will be conducted in this area in the nearest future.  
 
4.6. Theranostics  
Theranostics is an emerging and rapidly growing area, which deals with developing strategies 
for detecting or monitoring and simultaneously treating diseases. In the context of drug delivery 
and application of polyelectrolyte multilayer capsules, this can be achieved using 
multicompartment carriers.  The most relevant functionality here is to be able to encapsulate 
sensing molecules in some compartments, and medicine necessary for treatment into other 
compartments.[118] If the molecules are small enough, then this molecule can freely diffuse 
through the polymeric shell of capsules. On the other hand, if the sensor molecule is sufficiently 
large, then small ions and salts can freely diffuse through the shell providing means for 
diagnostics. In either case, molecules necessary for treatment of diseases will need to be 
released, which can be achieved by methods described above. Another strategy of using 
microcapsules for theranostics is to explore a polymeric shell as an interrogating surface, for 
instance in surface enhanced Raman sensing (SERS)[119],[120] and photoacoustic imaging.[121] In 
SERS approach, molecules either are physically/chemically interacting with plasmonic shell of 
microcapsules or stand close (few nanometers) to the surface, thus molecules can be 
spectroscopically recognized both in liquids and in the living cells.[99-102] Photoacoustic imaging 
of microcapsules is expected to contribute to non-invasive carrier visualization for delivery of 
molecules with in vivo distribution as well as specific treatment for the release of a payload.  
 
4.7 Corrosion protection  
Another application where release prominently stands out is the corrosion protection. Here 
polyelectrolyte multilayer capsules were used to on-demand release of anticorrosion protective 
  
20 
 
agents.[122] Control over the release from microcapsules was achieved by laser light, making the 
microcapsules as a complementary release vehicles in comparison to halloysite clay nanotubes 
proposed by Lvov et al[123], silica containers,[124] and other polyelectrolyte based assemblies.[125]  
 
4.8 Outlook  
Microcapsules exhibit a high potential for interesting applications due to flexibility of their 
construction, diversity of functionalization with nanoparticles and molecules, and availability 
of a variety of forms, shapes and multicompartmentalized structures. Different methods have 
been developed for encapsulation and release – providing a platform for using microcapsules. 
Looking in future, additional encapsulation methods would always be useful providing desired 
loading of capsules. Release methods are particularly essential because they bring necessary 
control over availability of delivered molecules. Further extension of the range of techniques 
available for release as well as adjusting their parameters to suit for essential applications will 
certainly find their applications, and should spur further research activities.  
 
5. Conclusion 
In conclusion, polyelectrolyte multilayer capsules have seen a wave of extensive developments 
and increased interest in the past decade. That led to identification of physico-chemical 
principles underlying the interaction of polyelectrolytes in the shell. This review presents 
release methods from polyelectrolyte multilayer capsules including relevant encapsulation as 
essential features of the capsules. Subsequently, recent advances, particularly relevant for drug 
delivery, are presented. A large number of interesting applications has been demonstrated 
including catalysis, drug delivery, intracellular delivery, light-induced release. Some of these 
studies provided important applications of capsules in bio-medicine and drug delivery, while 
others aim to help investigating important key processes relevant to biology. It is expected that 
these applications will grow in numbers, thus contributing to understanding fundamental 
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aspects in biology, chemistry, and physics. The area of drug delivery without doubts stands to 
benefit from these developments.  
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